SudarshanHebbarMD

Nephrology • Kansas City, MO

Physician

Join to view full profile

Dr. Hebbar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Hebbar's full profile

Already have an account?

Office
6530 Troost
Ste A17
Kansas City, MO 64131
Phone+1 816-361-0670

Fax+1 816-444-6936
Is this information wrong?

Education & Training

University of ChicagoFellowship, Nephrology, 1993 - 1995
Hennepin HealthcareResidency, Internal Medicine, 1989 - 1992
Tulane University School of MedicineClass of 1989

Certifications & Licensure

MO State Medical License 1995 - 2025

Clinical Trials

CM4620 Injectable Emulsion Versus Supportive Care in Patients With Acute Pancreatitis and SIRS Start of enrollment: 2018 Mar 12
Completed
Phase 2
A PK/PD Study of CM4620-IE in Patients With Acute Pancreatitis Start of enrollment: 2019 Jan 06
Completed
Phase 2

Publications & Presentations

PubMed

5 citations
Orai1 calcium channel inhibition prevents progression of chronic pancreatitis.
Viktória Szabó, Noémi Csákány-Papp, Marietta Görög, Tamara Madácsy, Árpád Varga, Aletta Kiss, Bálint Tél, Boldizsár Jójárt, Tim Crul, Krisztina Dudás, Mária Bagyánszki...> ;JCI Insight. 2023 Jul 10
15 citations
Auxora vs. placebo for the treatment of patients with severe COVID-19 pneumonia: a randomized-controlled clinical trial.
Charles Bruen, Mukhtar Al-Saadi, Edward A Michelson, Maged Tanios, Raul Mendoza-Ayala, Joseph Miller, Jeffrey Zhang, Kenneth Stauderman, Sudarshan Hebbar, Peter C Hou> ;Critical Care. 2022 Apr 8
9 citations
Auxora for the Treatment of Patients With Acute Pancreatitis and Accompanying Systemic Inflammatory Response Syndrome: Clinical Development of a Calcium Release-Activa...
Charles Bruen, Joseph Miller, John Wilburn, Caleb Mackey, Thomas L Bollen, Kenneth Stauderman, Sudarshan Hebbar> ;Pancreas. 2021 Apr 1
4 citations
Derivation and validation of the ED-SAS score for very early prediction of mortality and morbidity with acute pancreatitis: a retrospective observational study.
Joseph B Miller Md, Yiyang Wu, Georgiana Marusca, Sandeep Bhatti, Guneet Ahluwalia, Jad Dandashi, Harold Gomez Acevedo, Naureen Farook, Ashley Scott, Vidhya Nair, Angi...> ;BMC Emergency Medicine. 2021 Jan 28
42 citations
Auxora versus standard of care for the treatment of severe or critical COVID-19 pneumonia: results from a randomized controlled trial.
Joseph B Miller Md, Charles A. Bruen, Michael Schnaus, Jeffrey Zhang, Sadia Ali, April Lind, Zachary Stoecker, Kenneth A. Stauderman, Sudarshan Hebbar> ;Critical Care. 2020 Aug 14
22 citations
Microglial Calcium Release-Activated Calcium Channel Inhibition Improves Outcome from Experimental Traumatic Brain Injury and Microglia-Induced Neuronal Death.
Atsushi Mizuma, Jong Youl Kim, Rachid Kacimi, Kenneth A. Stauderman, Michael J. Dunn, Sudarshan Hebbar, Midori A. Yenari> ;Journal of Neurotrauma. 2019 Mar 20
Join now to see all

Press Mentions

CalciMedica’s Drug Lowers Mortality Rate in Phase II Covid-19 TrialSeptember 15th, 2021
CalciMedica Announces IDMC Recommendation to Continue with Trial Evaluating Auxora™ in Patients with Severe COVID-19 PneumoniaDecember 17th, 2020
CalciMedica Announces Senior Clinical Development HireNovember 14th, 2016

SudarshanHebbarMD

Dr. Hebbar is on Doximity

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Press Mentions

Viewing the full profile is available to verified healthcare professionals only.